TCR2 Therapeutics Inc. (TCRR)
NASDAQ: TCRR
· Real-Time Price · USD
1.48
0.00 (0.00%)
At close: May 31, 2023, 10:00 PM
TCR2 Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -41.51M | -61.42M | -31.1M | -31.77M | -29.2M | -27.58M | -26.24M | -24.29M | -21.59M |
Interest Income | 1.11M | 1.01M | 510K | 298K | 117K | 38K | 38K | n/a | n/a |
Pretax Income | -40.4M | -60.41M | -30.59M | -31.47M | -29.09M | -27.58M | -26.2M | -24.26M | -21.48M |
Net Income | -40.4M | -60.51M | -30.59M | -31.6M | -29.12M | -27.74M | -26.24M | -24.31M | -21.51M |
Selling & General & Admin | 8.2M | 5.8M | 6.31M | 6M | 6.32M | 5.21M | 5.96M | 5.67M | 5.67M |
Research & Development | 29.27M | 25.74M | 24.79M | 25.77M | 22.88M | 22.41M | 20.28M | 18.63M | 15.92M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 37.47M | 31.54M | 31.1M | 31.77M | 29.2M | 27.62M | 26.24M | 24.29M | 21.59M |
Interest Expense | 6.97M | n/a | n/a | 298K | 117K | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 37.47M | 31.54M | 31.1M | 31.77M | 29.2M | 27.62M | 26.24M | 24.29M | 21.59M |
Income Tax Expense | 3K | 96K | 1K | 128K | 36K | 160K | 42K | 51K | 36K |
Shares Outstanding (Basic) | 39.22M | 38.81M | 38.62M | 38.57M | 38.51M | 38.29M | 38.2M | 38.18M | 37.06M |
Shares Outstanding (Diluted) | 39.22M | 38.81M | 38.62M | 38.57M | 38.51M | 38.29M | 38.2M | 38.18M | 37.06M |
EPS (Basic) | -1.03 | -1.56 | -0.79 | -0.82 | -0.76 | -0.72 | -0.69 | -0.64 | -0.58 |
EPS (Diluted) | -1.03 | -1.56 | -0.79 | -0.82 | -0.76 | -0.72 | -0.69 | -0.64 | -0.58 |
EBITDA | -32.81M | -1.66M | -30.21M | -31.07M | -28.5M | -26.73M | -25.43M | -23.57M | -20.96M |
EBIT | -33.42M | -60.82M | -31.1M | -31.18M | -28.97M | -27.58M | -26.24M | -24.29M | -21.59M |
Depreciation & Amortization | 8.7M | 59.77M | 890K | 704K | 706K | 851K | 773K | 690K | 513K |